相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Metabolites in Safety Testing: MIST for the Clinical Pharmacologist
C. B. Frederick et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Quantifying the Metabolic Activation of Nevirapine in Patients by Integrated Applications of NMR and Mass Spectrometries
Abhishek Srivastava et al.
DRUG METABOLISM AND DISPOSITION (2010)
Overview of metabolite safety testing from an industry perspective
Shelby Anderson et al.
BIOANALYSIS (2010)
Which Human Metabolites Have We MIST? Retrospective Analysis, Practical Aspects, and Perspectives For Metabolite Identification and Quantification in Pharmaceutical Development
Laurent Leclercq et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Interpretation and Considerations on the Safety Evaluation of Human Drug Metabolites
Aisar H. Atrakchi
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
A Holistic Strategy for Characterizing the Safety of Metabolites through Drug Discovery and Development
Don Walker et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Predicting Circulating Human Metabolites: How Good Are We?
Shelby Anderson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Obtaining Exposures of Metabolites in Preclinical Species through Plasma Pooling and Quantitative NMR: Addressing Metabolites in Safety Testing (MIST) Guidance without Using Radiolabeled Compounds and Chemically Synthesized Metabolite Standards
Karthick Vishwanathan et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Approaches to the Assessment of Stable and Chemically Reactive Drug Metabolites in Early Clinical Trials
Thomas A. Baillie
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Nuclear Magnetic Resonance Spectroscopy as a Quantitative Tool To Determine the Concentrations of Biologically Produced Metabolites: Implications in Metabolites in Safety Testing
Robert Espina et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Metabolites in Safety Testing (MIST): Considerations of Mechanisms of Toxicity with Dose, Abundance, and Duration of Treatment
Dennis A. Smith et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Safety testing of metabolites: Expectations and outcomes
K. Sandy Pang
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Clearing the MIST (metabolites in safety testing) of time: The impact of duration of administration on drug metabolite toxicity
Dennis A. Smith et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Metabolites in safety testing
Timothy W. Robison et al.
BIOANALYSIS (2009)
Unique/major human metabolites: Why, how, and when to test for safety in animals
Debra Luffer-Atlas
DRUG METABOLISM REVIEWS (2008)
Determination of relative response factors of impurities in paclitaxel with high performance liquid chromatography equipped with ultraviolet and charged aerosol detectors
Ping Sun et al.
JOURNAL OF CHROMATOGRAPHY A (2008)
A rapid method for quantitatively estimating metabolites in human plasma in the absence of synthetic standards using a combination of liquid chromatography/mass spectrometry and radiometric detection
ChungPing Yu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
Metabolites and safety: What are the concerns, and how should we address them?
Dennis A. Smith et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Safety assessment of drug metabolites: Characterization of chemically stable metabolites
W. Griffith Humphreys et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Safety assessment of stable drug metabolites
F. Peter Guengerich
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
A regulatory perspective on issues and approaches in characterizing human metabolites
Karen L. Davis-Bruno et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Drug metabolites in safety testing
TA Baillie et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2002)